ZimVie to be acquired by Archimed for $19.00 per share in cash

ZimVie to be acquired by Archimed for $19.00 per share in cash
ZimVie jumps after report on buyout talks with South Korea’s Osstem
ZimVie may be worth $25-$29 a share in takeover - analyst
Dental implant maker ZimVie jumps after report it's evaluating sale
ZimVie jumps amid report of takeover interest
535.72MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US98888T1079
CUSIP
98888T107
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
14.64
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.69
Wall Street Target Price
19.00
EPS Estimate Current Year
0.91
EPS Estimate Next Year
0.94
EPS Estimate Current Quarter
0.208
EPS Estimate Next Quarter
0.189
Most Recent Quarter
-
Revenue TTM
443,401,984
Gross Profit TTM
289,571,008
EBITDA
40,964,000
Profit Margin
-4.39%
Return On Assets TTM
0.51%
Return On Equity TTM
-4.76%
Revenue Per Share TTM
15.984
Qtly Revenue Growth YOY
-0.10%
Diluted Eps TTM
-0.69
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
22
Price Sales TTM
1.2082
Price Book MRQ
1.2944
Enterprise Value Revenue
1
Enterprise Value EBITDA
16
30.47
2.94%89.41
2.82%26.19
1.49%40.28
0.84%26.77
0.70%19.65
0.00%243.88
0.00%13.10
-3.18%10.01
-2.72%39.22
-1.26%